The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk, the manufacturer of ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...

Elevated Capital Advisors LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 20.8% in the ...

Eli Lilly And Co’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 34.50% and a profit margin of 18.86%, with a gross margin of 23.36%. The ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval ...

Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Waldron Private Wealth LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the 3rd ...